Company
MedLeanRx
MedLeanRx publishes compounded semaglutide and compounded tirzepatide, from $149 to $269 a month.
- 3 programs
- 2 molecules
- 3 readings
Read from medleanrx.com on September 2, 2026. This page records what the company publishes. It is not a review and takes no position on the company.
Go to MedLeanRx
We earn nothing from this link. MedLeanRx has no commercial arrangement with Treatment Registry, and its record here is kept to the same standard as every other.
What it costs
first month, including the required fees on record · Semaglutide Vial
first month, including the required fees on record · Semaglutide Tablets
first month, including the required fees on record · Tirzepatide injections, starting price
Terms
| Membership | Optional, $99 per month. FDA-Approved FDA-Approved Oral Wegovy® Semaglutide Wegovy® Pill $99 /mo + medication cost |
|---|---|
| States | Not disclosed as of September 3, 2026 |
Not yet checked: pharmacy and consultation fee.
Terms can differ between this company’s programs; each entry carries its own.
Programs
Notes
Recorded against this company rather than one program.
September 2, 2026
- 1. Contradiction: the homepage badges advertise 'Cancel Anytime,' while the Terms page states a strict NO-REFUND policy covering subscription/membership/admin fees. The '$99/mo + medication cost' Wegovy Pill tier explicitly excludes medication and is recorded as membership, not a price, per the brief's rule. Terms also state 'MedLeanRX Services are not available in all 50 states,' consistent with the Texas-only marketing.
Before you act
Cite this
Treatment Registry. (2026). MedLeanRx: recorded programs and prices. Last verified September 2, 2026. Retrieved [your access date], from https://treatmentregistry.com/providers/medleanrx